Clinical trials
Completed Mycoses trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 69 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 9 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 7 |
| Pfizer | 6 |
| University of Pittsburgh | 6 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 4 |
| Children's Oncology Group | 3 |
| University of California, San Francisco | 3 |
| Astellas Pharma Inc | 2 |
| M.D. Anderson Cancer Center | 2 |
| Merz North America, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mycoses | 69 |
| Candidiasis | 13 |
| Fungemia | 10 |
| Aspergillosis | 8 |
| Candidemia | 7 |
| Invasive Fungal Infections | 7 |
| HIV Infections | 6 |
| Infections | 6 |
| Bacterial Infections | 5 |
| Candidiasis, Invasive | 5 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.